Picture of Seer logo

SEER — Seer News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousSmall CapNeutral

Brief: Seer Q2 EPS USD -0.33

Overview

Seer Q2 revenue grows 32% yr/yr to $4.1 mln, driven by product sales

Operating expenses decreased 21% due to lower stock-based compensation

Net loss narrowed to $19.4 mln from $22.9 mln in prior year

Outlook

Seer expects 2025 revenue to be $17 mln to $18 mln

Company anticipates 24% revenue growth for full year 2025

Result Drivers

PRODUCT SALES - Revenue growth driven by increased sales of Proteograph instruments and consumable kits

NEW PRODUCT LAUNCHES - Launch of Proteograph ONE assay and SP200 instrument enhanced scalability and efficiency

COLLABORATION - Partnership with Korea University for a large-scale study utilizing Proteograph ONE assay

Key Details

MetricBeat/MissActualConsensus Estimate
Q2 Revenue$4.05 mln
Q2 EPS-$0.33
Q2 Net Income-$19.42 mln
Q2 Gross Margin52.0%
Q2 Gross Profit$2.11 mln
Q2 Operating Expenses$22.64 mln
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell" The average consensus recommendation for the office equipment peer group is "buy" Press Release: ID:nGNX7jW8wY (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Seer

See all news